Sequential antibiotic therapy

被引:12
作者
Barlow, GD [1 ]
Nathwani, D [1 ]
机构
[1] Tayside Univ, Teaching Hosp, Kings Cross Hosp,Infect & Immunodeficiency Unit, Dept Infect & Immunodeficiency, Dundee, Scotland
关键词
D O I
10.1097/00001432-200012000-00004
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Antimicrobials are an important source of hospital expenditure. Traditionally, severe bacterial infections have been treated initially with intravenous antibiotics, followed by physician-directed switch to oral therapy. Unfortunately this approach results in unnecessary prolongation of intravenous treatment, with all its inherent disadvantages. Sequential antibiotic therapy, however, ensures an early switch to the oral route when the patient is clinically stable. This increasingly employed strategy is safe and results in improved quality and cost-effectiveness of health care. To ensure timely and appropriate switch, such programmes need to be underpinned by clear guidelines and supported by a multidisciplinary team. In the future, key questions. such as what is the optimal time of switch for specific infections, and can conditions such as osteomyelitis and endocarditis be efficaciously treated with oral therapy, need to be answered. Only then will clinicians be able to practise evidence-based infection management incorporating sequential antimicrobial therapy. Curr Opin Infect Dis 13:599-607. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:599 / 607
页数:9
相关论文
共 57 条
[1]  
Ahkee S, 1997, PHARMACOTHERAPY, V17, P569
[2]  
[Anonymous], 1998, ANTIMICROBIAL RESIST
[3]  
[Anonymous], ANTIBIOTIC CHEMOTHER
[4]  
*ASS BRIT PHARM IN, 1999, COMP DAT SHEETS SUMM, P1165
[5]   Reevaluation of outpatients with Streptococcus pneumoniae bacteremia [J].
Bachur, R ;
Harper, MB .
PEDIATRICS, 2000, 105 (03) :502-509
[6]  
Bailey RR, 1996, CLIN NEPHROL, V46, P183
[7]  
Balfour J A, 1993, Pharmacoeconomics, V3, P398, DOI 10.2165/00019053-199303050-00007
[8]   Community-acquired pneumonia in adults: Guidelines for management [J].
Bartlett, JG ;
Breiman, RF ;
Mandell, LA ;
File, TM .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) :811-838
[9]  
BARTLETT JG, 1994, INFECT DIS CLIN PRAC, V2, P405
[10]  
Boyter AC, 1997, J ANTIMICROB CHEMOTH, V39, P286